Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Understanding hair follicle anatomy helps diagnose hair disorders.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

A new surgical technique using vellus hair grafts effectively treated vitiligo without causing unwanted hair growth.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Dr. SKS Hair Booster Serum effectively treats hair loss in women with PCOS.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

N793 may improve hair density in people with mild hair thinning.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Hair becomes gray and thin as we age, and while most hair loss in older people is due to genetics, there's a chance for gray hair to regain color under certain conditions.

Neonate scalp hair is thinner, lacks a medulla, and has smaller follicles compared to adult hair.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

ALDOA levels drop in hair cells during hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.